Advanced care using the latest technology to achieve optimal glucose control with less daily burden


Type 1 diabetes affects children and adults, requiring constant attention to blood glucose and insulin dosing. For many who have lived with it for decades, this can be stressful and exhausting. On the one hand, a glucose spike creates the need for correction, bringing feelings of guilt and requiring immediate action. On the other hand, dropping glucose causes worry and again demands a response—24/7, 365 days a year.
But diabetes care has changed dramatically. These swings can now be minimized, stress can be managed, time in healthy range of over 90% is achievable, and progress for our patients has never been more rapid. You deserve better. I’m at the forefront of bringing these innovations to my patients—let me show you what we can do for you.
Revolutionary technologies are transforming how we manage Type 1 diabetes
I’ve been using hybrid closed-loop pumps for several years now, with the Omnipod 5 patch pump proving most popular with patients. Exciting developments are on the horizon: complete closed-loop technology (Omnipod 6), new continuous glucose and ketone monitoring, smaller and lighter pumps, and increasing competition that will help reduce costs. 2026 promises to be full of innovation
The breakthrough is simultaneous ketone monitoring, which can predict dangerous DKA episodes before they happen. This is especially valuable for patients using SGLT2 inhibitors or GLP-1 medications alongside their insulin
If you prefer taking your mealtime insulin at the start of eating, consider faster-acting insulins like Fiasp or Lyumjev. Smart Pens can help ensure you never forget your meal doses
These technologies work together to achieve very tight in-range glucose readings with less effort.
Less stress, more freedom, and the ability to eat more sensibly while maintaining excellent control.
Islet and stem cell infusions are on the horizon and can effectively treat Type 1 diabetes while they remain active—usually 8-12 weeks. Teplizumab and other medicines in clinical trials can delay the onset of Type 1 diabetes in at-risk patients with early Stage 2 disease. I’m actively involved in bringing these innovations to my patients
Dr. Abraham was an early champion of bringing cutting-edge diabetes technology to the UK private sector

The system continuously monitors glucose levels, calculates insulin needs, and automatically adjusts delivery - like an artificial pancreas.

Modern insulin pumps like the Omnipod offer tubeless, discreet diabetes management
A pioneer in advanced diabetes technology with a focus on patient education and support
Extensive experience with Medtronic, Tandem, and Omnipod closed-loop systems
Use of GLP-1 agonists (Ozempic, Mounjaro) for Type 1 when beneficial
Safe use of Forxiga, Jardiance, Invokana with proper ketone monitoring education
For antibody-positive individuals to delay insulin requirements by 2-3 years
Work with diabetes nurse specialists and dietitians for complete care
Affordable comprehensive management packages for regular monitoring and optimization
Schedule a consultation to discuss how the latest diabetes technology can improve your quality of life.